Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.42B |
| 2 |
Vale
VALE
|
+$1.05B |
| 3 |
Freeport-McMoran
FCX
|
+$988M |
| 4 |
Micron Technology
MU
|
+$690M |
| 5 |
ExxonMobil
XOM
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.21B |
| 2 |
TC Energy
TRP
|
+$1.37B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Verizon
VZ
|
+$1.31B |
| 5 |
Amazon
AMZN
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 16.54% |
| 3 | Communication Services | 12.92% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
MaxLinear
MXL
$6.74B
| $48.5M | 0.02% |
1,900,000
| – | – |
|
327
MACOM Technology Solutions
MTSI
$23.7B
| $48.4M | 0.02% |
2,896,000
-1,318,764
| -31% | -$23M |
|
|
PPL
328
PPL Corp
PPL
$26.7B
| $48.3M | 0.02% |
1,522,150
| – | – |
|
|
BAND
329
Bandwidth Inc
BAND
$1.67B
| $48M | 0.02% |
717,302
+278,091
| +63% | +$14.6M |
|
|
FISV
330
Fiserv Inc
FISV
$27.4B
| $47.4M | 0.02% |
536,700
-2,758,403
| -84% | -$228M |
|
331
Kinetik
KNTK
$4.12B
| $47.2M | 0.02% |
799,900
-10,000
| -1% | -$740K |
|
332
Emerson Electric
EMR
$91.4B
| $46.7M | 0.01% |
681,850
| – | – |
|
333
Trupanion
TRUP
$1.33B
| $46M | 0.01% |
1,404,194
| – | – |
|
334
Mondelez International
MDLZ
$79.4B
| $44.3M | 0.01% |
887,000
| – | – |
|
335
Thor Industries
THO
$4.11B
| $43.8M | 0.01% |
701,600
+158,600
| +29% | +$10M |
|
|
VRNT
336
DELISTED
Verint Systems
VRNT
| $43.5M | 0.01% |
1,425,138
-628,160
| -31% | -$16M |
|
337
Avient
AVNT
$4.16B
| $42.8M | 0.01% |
1,459,000
| – | – |
|
338
Motorola Solutions
MSI
$77.7B
| $42.1M | 0.01% |
300,000
| – | – |
|
|
CY
339
DELISTED
Cypress Semiconductor
CY
| $41.8M | 0.01% |
2,800,000
| – | – |
|
|
AYX
340
DELISTED
Alteryx Inc
AYX
| $39.4M | 0.01% |
+469,900
| New | +$33.9M |
|
341
Silicon Laboratories
SLAB
$7.22B
| $37.4M | 0.01% |
463,000
| – | – |
|
|
DHR.PRA
342
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $36.9M | 0.01% |
+35,000
| New | +$36.1M |
|
343
Edison International
EIX
$26.7B
| $36.8M | 0.01% |
595,103
-343,659
| -37% | -$20.5M |
|
|
FDC
344
DELISTED
First Data Corporation
FDC
| $36.8M | 0.01% |
1,399,541
| – | – |
|
345
Vail Resorts
MTN
$5.29B
| $36.2M | 0.01% |
166,426
| – | – |
|
|
AIFU
346
AIFU Inc
AIFU
$218M
| $35.4M | 0.01% |
3,371
+11
| +0.3% | +$109K |
|
347
Levi Strauss
LEVI
$8.64B
| $35.3M | 0.01% |
+1,500,000
| New | +$33.6M |
|
348
National Vision
EYE
$1.56B
| $34.6M | 0.01% |
1,100,000
| – | – |
|
349
Lands' End
LE
$391M
| $34.5M | 0.01% |
2,078,232
| – | – |
|
|
NUVA
350
DELISTED
NuVasive, Inc.
NUVA
| $34.1M | 0.01% |
600,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q1 2019 Portfolio in Review
As of Q1 2019, Capital Research Global Investors held 442 positions worth $315B, up 9.9% from $287B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2019 filing shows 25 new, 151 increased, 166 reduced and 27 closed positions. Its largest new stake was Micron Technology: 17,867,672 shares worth $738M. The largest sale was AbbVie, an estimated $2.21B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2019 buy was Micron Technology: 17,867,672 shares worth $738M.
- Capital Research Global Investors added most to Alibaba in Q1 2019, an estimated $1.42B increase.
- Capital Research Global Investors's biggest Q1 2019 reduction was AbbVie, cutting an estimated $2.21B.
- Capital Research Global Investors fully exited TC Energy in Q1 2019, selling an estimated $1.37B.
- Capital Research Global Investors's ten largest holdings make up 27% of its $315B portfolio in Q1 2019.
- Capital Research Global Investors opened 25 new positions and closed 27 in Q1 2019.
- Capital Research Global Investors's portfolio value rose 9.9% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q1 2019, filed 15 May 2019.